Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q3 2016)

As of Sep 30, 2016, the Muhlenkamp & Co portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 06, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2016, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q3 2016
AAPL
Apple Inc.
Sell
-519
Q3 2016
ALGT
Allegiant Travel Company
Buy
+257
Q3 2016
BFH
Bread Financial Holdings, Inc.
Sell
-624
Q3 2016
BIIB
Biogen Inc.
Sell
-225
Q3 2016
BMY
Bristol-Myers Squibb Company
Sell
-1,024
Q3 2016
CE
Celanese Corporation
Sell
-850
Q3 2016
CYH
Community Health Systems, Inc.
Sell
-1,865
Q3 2016
DAL
Delta Air Lines, Inc.
Buy
+300
Q3 2016
GILD
Gilead Sciences, Inc.
Sell
-2,505
Q3 2016
GLD
SPDR Gold Trust
Sell
-605
Q3 2016
HBI
Hanesbrands Inc.
Sell
-2,450
Q3 2016
MCK
McKesson Corporation
Sell
-430
Q3 2016
MGNX
MacroGenics, Inc.
Sell
-3,673
Q3 2016
MS
Morgan Stanley
Buy - Position Entry
+6,505
Q3 2016
MSFT
Microsoft Corporation
Sell
-800
Q3 2016
OLED
Universal Display Corporation
Buy
+430
Q3 2016
ON
ON Semiconductor Corporation
Sell
-6,470
Q3 2016
PFE
Pfizer, Inc.
Sell
-1,015
Q3 2016
RUSHB
Rush Enterprises, Inc.
Buy
+1,300
Q3 2016
SAVE
Spirit Airlines, Inc.
Sell
-1,275
Q3 2016
SLB
Schlumberger N.V.
Sell
-95
Q3 2016
TCEHY
Tencent Holding Ltd.
Buy - Position Entry
+252,393
Q3 2016
TEVA
Teva Pharmaceutical Industries
Sell
-885
Q3 2016
UNH
UnitedHealth Group Incorporated
Sell
-560